Objective To investigate the association between the intensity of climacteric symptoms and sexual dysfunction in women aged 40 to 65 years. Methods Observational, analytic, cross-sectional study conducted with 63 women aged 40 to 65 treated at the gynecology outpatient clinic of a public hospital in northeastern Brazil. A questionnaire was used to collect identification data, clinical information, gynecological-obstetric data, lifestyle traits and information on chronic diseases. Climacteric symptoms and sexual function were evaluated by means of the Blatt-Kupperman index and the Female Sexual Function Index (FSFI) respectively. The association between the two indices was investigated using the chi-squared test; the difference in mean scores on the FSFI as a function of menopausal status was evaluated by Student's t-test. The significance level was set to p < 0.05. Results The mean value of the Blatt-Kupperman index was 26.42 (standard deviation [SD]: 4.52); 36.51% of the women exhibited severe symptoms. The mean score on the FSFI was 21.84 (SD: 4.11). More than half of the analyzed women (58.73%) exhibited sexual dysfunction (FSFI 26.5). Regarding the association between the BlattKupperman index and the FSFI, the greater the intensity of the climacteric symptoms (Blatt-Kupperman), the higher the frequency of sexual dysfunction (FSFI). Sexual dysfunction was exhibited by 100% of the participants with severe climacteric symptoms, 70.59% of those with moderate symptoms, and only 9.09% with mild symptoms (p < 0.001). Conclusions The application of the Blatt-Kupperman index and of the FSFI allowed the detection of an association between the severity of climacteric symptoms and the prevalence of sexual dysfunction.
Introduction
The climacteric is a period characterized by a physiological state of progressive hypoestrogenism; it begins at approximately age 40, and extends until age 65, marking the transition from the reproductive phase to the non-reproductive state.
1,2 The hormonal changes related to the climacteric are perceptible due to the state of hypoestrogenism, which is accompanied by a characteristic set of symptoms, including hot flashes, paresthesia, joint pain, muscle pain, headache, night sweats, vaginal dryness, weakening of the pelvic floor muscles, dyspareunia, insomnia and mood disorders. 3, 4 After menopause, the epithelium of the genital tract becomes thinner, the secretions of the sudoriferous and sebaceous glands of the vulva decrease, the Bartholin's glands atrophy, lubrication decreases, and the vagina becomes narrower, with consequent reduction of its rugae and elasticity. 5 Cabral et al 3 found an inverse correlation between sexual function and climacteric symptoms. Upon analyzing each of the phases of the sexual response separately, they found that the factors that most contributed to the low scores exhibited by the women with high risk of sexual dysfunction were arousal, orgasm and pain. In another study, Valadares et al 6 detected sexual dysfunction in climacteric women. They concluded that being 50 years of age or older; going through the menopausal transition or postmenopause; not having a sexual partner; reporting hot flashes, insomnia, depression, nervousness, sedentary lifestyle, arterial hypertension, or urinary incontinence; and poor self-perception of health were significantly associated with a below median sexuality score. From the cultural perspective, menopause is a symbol of aging and decrepitude; its occurrence might result in poorer self-esteem and loss of sexual desire. [7] [8] [9] In their study with 370 climacteric women from Natal, Rio Grande do Norte, Brazil, Cabral et al 3 found an association between the climacteric symptoms and the worsening of sexual dysfunction. Despite the relevance of this subject, few studies have investigated the specific aspects of sexual function during the climacteric. More thorough knowledge of this problem will lead to better care for menopausal women, improving their quality of life.
The aim of the present study was to investigate the relationship between the intensity of climacteric symptoms and sexual dysfunction in women aged 40 to 65 years. The Blatt-Kupperman index was used to assess the intensity of the climacteric syndrome, and the Female Sexual Function Index (FSFI) was used as a predictor of sexual dysfunction in this population. 
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Methods
The present observational, analytic and cross-sectional study was conducted with a sample comprising 63 women aged 40 to 65 treated at the gynecology outpatient clinic of a public hospital in Brazil. Data were collected from May to September 2015.
All the women aged 40 to 65 years old who spontaneously sought care at the gynecology outpatient clinic and were not taking hormone replacement therapy were invited to participate in the study. Explicit refusal, inability to participate and the presence of any factor hindering the performance of interviews (for instance, a psychiatric disease) were considered exclusion criteria, as was the use of neuroleptics, anxiolytics or antidepressants, as sexual dysfunction is one of the main side effects of these drugs.
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Women waiting for medical consultation were randomly selected and individually invited to participate. After the details of the study were explained, the women who agreed to participate signed an informed consent form and were sent to a private room to be individually interviewed by the investigator.
A protocol form was filled out first, which contained identification data and clinical information. The following data were collected: age, skin color, civil status, educational level, income and occupation. The clinical information was evaluated based on gynecological-obstetric data, lifestyle and the presence of chronic diseases.
Next, the participants verbally answered the questions included in the instruments for assessing climacteric symptoms and sexual function. The climacteric symptoms were evaluated based on the Blatt-Kupperman index, which measures the intensity of several symptoms as reported by the respondent. Symptom severity is considered mild when the score is equal to or lower than 19; moderate, from 20 to 35; and severe, above 35.
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The symptoms included are hot flashes, paresthesia, insomnia, nervousness, depression, fatigue, arthralgia/myalgia, headache, palpitations and tingling.
The participants' sexual function was evaluated using the FSFI, which is a high-quality instrument recommended for use with women. 12 The FSFI was translated and validated for use with Portuguese-speaking populations. It assesses key dimensions of female sexual function in the previous four weeks. It comprises 19 questions divided into 5 domains of the sexual response: desire, arousal, lubrication, orgasm satisfaction and vaginal pain or discomfort. Scores equal to or lower than 26.5 are considered to represent high risk of sexual dysfunction.
13,14
Following the data collection, an exploratory analysis was performed, in which the sample was described as to its sociodemographic, clinical, gynecological-obstetrical and behavioral characteristics. The mean and standard error of the FSFI domain scores were calculated according to the categorization of risk of sexual dysfunction as positive (FSFI 26.5) or negative. The climacteric symptoms (Blatt-Kupperman index) were categorized on an ordinal scale according to their intensity (mild, moderate or severe).
The association between the intensity of the climacteric symptoms and the presence of sexual dysfunction was assessed by the chi-squared test. Regarding the number of pregnancies, 14.29% of the women were nulliparous, and 73.02% were multiparous. Fifty-three (84.13%) women did not have a history of abortion. A total of 36.51% of the participants had hypertension, and 11.11% had diabetes (►Table 1).
The mean Blatt-Kupperman index score was 24.42 (SD: 4.52). Severe climacteric symptoms were presented by 23 (36.51%) women. The distribution of the participants according to the Blatt-Kupperman index score is described in ►Table 1.
The total FSFI score was 21.84 (SD: 4.11), and 37 (58.73%) women had FSFI 26.5. The proportion of subjects according to the total FSFI score is described in ►Table 1.
Premenopausal women had higher total FSFI scores then postmenopausal women (respectively, a total FSFI of 26. There was an association between the Blatt-Kupperman index and the FSFI total score 26.5 (p < 0.01). All 23 women with severe climacteric symptoms exhibited total FSFI scores 26.5. Among the 17 participants with moderate symptoms, 12 (70.59%) had total FSFI scores 26.5. Among the 22 participants with mild symptoms, 2 (9.09%) had total FSFI scores 26.5 (p < 0.001). The analysis of the association between the Blatt-Kupperman index and the FSFI is described in ►Table 2.
Discussion
The prevalence of sexual dysfunction found in the study population was similar to the prevalence previously reported for the Northeastern, Midwestern, Southern and Southeastern regions of Brazil (50 to 67%). 24, 25 showed that the proportion of women with sexual dysfunction gradually increases from the beginning to the last phase of the menopausal transition. In a study in Chile, Castelo-Branco et al 26 found that 51.3% of the sexually active women exhibited sexual dysfunction, and that the latter increased with age. The results of these two studies corroborate the present study, in which sexual dysfunction prevailed among the menopausal (older) women compared with the premenopausal (younger) women. In the study by Mishra and Kuh, 27 somatic symptoms and hot flashes/cold sweats were associated with difficulties with intercourse, while psychological symptoms, stressful lives and increasing age were associated with a decline in sex life. These findings agree with the present study, in which the intensity of climacteric symptoms was associated with the presence of sexual dysfunction. In the present study, 36.51% of the participants had hypertension, and 11.11% had diabetes. Although none of these comorbidities were associated with climacteric symptoms or sexual dysfunction, previous studies found that both influence sexual function negatively.
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Overall, the severity of the climacteric symptoms in the analyzed sample was moderate (26.42 The results of the present study should be interpreted cautiously, given the study's limitations: the sexual dysfunction was assessed based on the participants' self-report, and female aging is accompanied by signs and symptoms of its own, which, added to biopsychosocial factors, interfere with the women's sexual function. Nevertheless, our results indicate a positive association between the intensity of the climacteric symptoms (Blatt-Kupperman) and the prevalence of sexual dysfunction (FSFI). The rise in the prevalence of sexual dysfunction in menopause suggests the need for doctors to pay attention to the sexual sphere at each gynecological visit; the climacteric is influenced by a culture characterized by prejudice against women, fear and myths, and as a function of educational factors, many women are led to experience sexual intercourse in an unsatisfactory way at this stage of life. Accurate knowledge of the climacteric as a whole is important for the promotion of a better quality of life for aging women. 
